Open Access Open Access  Restricted Access Subscription Access

Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine


Affiliations
1 Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, WI 54449, United States
 

Advances in genomic medicine have the potential to change the way we treat human disease, but translating these advances into reality for improving healthcare outcomes depends essentially on our ability to discover disease-and/or drug-associated clinically actionable genetic mutations. Integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a big data infrastructure can provide an efficient and effective way to identify clinically actionable genetic variants for personalized treatments and reduce healthcare costs. We review bioinformatics processing of next-generation sequencing (NGS) data, bioinformatics infrastructures for implementing precision medicine, and bioinformatics approaches for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.
User
Notifications
Font Size

Abstract Views: 45

PDF Views: 0




  • Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine

Abstract Views: 45  |  PDF Views: 0

Authors

Tonia C. Carter
Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, WI 54449, United States
Max M. He
Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, WI 54449, United States

Abstract


Advances in genomic medicine have the potential to change the way we treat human disease, but translating these advances into reality for improving healthcare outcomes depends essentially on our ability to discover disease-and/or drug-associated clinically actionable genetic mutations. Integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a big data infrastructure can provide an efficient and effective way to identify clinically actionable genetic variants for personalized treatments and reduce healthcare costs. We review bioinformatics processing of next-generation sequencing (NGS) data, bioinformatics infrastructures for implementing precision medicine, and bioinformatics approaches for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.